Diabetes Technology & Therapeutics · 2014 · 55 citations · 34 references
MedicineEndocrinologyInternal MedicineClinical Decision SupportClinical NutritionDiabetologyBlood Glucose MonitoringContinuous Glucose MonitoringDiabetes ControlDiabetes MellitusGlycemic ControlGlycemic MonitoringArtificial Pancreas MonitoringArtificial Pancreas SystemsBlood Glucose CorrectionBlood Glucose RegulationClosed-loop Insulin TherapyContinuous Glucose Monitoring Guided TherapyDiabetes Complications ManagementDiabetes-related Complications
BACKGROUND: Closed-loop control of blood glucose levels in people with type 1 diabetes offers the potential to reduce the incidence of diabetes complications and reduce the patients' burden, particularly if meals do not need to be announced. We therefore tested a closed-loop algorithm that does not require meal announcement. MATERIALS AND METHODS: A multiple model probabilistic predictive controller (MMPPC) was assessed on four patients, revised to improve performance, and then assessed on six additional patients. Each inpatient admission lasted for 32 h with five unannounced meals containing approximately 1 g/kg of carbohydrate per admission. The system used an Abbott Diabetes Care (Alameda, CA) Navigator(®) continuous glucose monitor (CGM) and Insulet (Bedford, MA) Omnipod(®) insulin pump, with the MMPPC implemented through the artificial pancreas system platform. The controller was initialized only with the patient's total daily dose and daily basal pattern. RESULTS: On a 24-h basis, the first cohort had mean reference and CGM readings of 179 and 167 mg/dL, respectively, with 53% and 62%, respectively, of readings between 70 and 180 mg/dL and four treatments for glucose values <70 mg/dL. The second cohort had mean reference and CGM readings of 161 and 142 mg/dL, respectively, with 63% and 78%, respectively, of the time spent euglycemic. There was one controller-induced hypoglycemic episode. For the 30 unannounced meals in the second cohort, the mean reference and CGM premeal, postmeal maximum, and 3-h postmeal values were 139 and 132, 223 and 208, and 168 and 156 mg/dL, respectively. CONCLUSIONS: The MMPPC, tested in-clinic against repeated, large, unannounced meals, maintained reasonable glycemic control with a mean blood glucose level that would equate to a mean glycated hemoglobin value of 7.2%, with only one controller-induced hypoglycemic event occurring in the second cohort.
34
Translating the A1C Assay Into Estimated Average Glucose Values
David M. Nathan, J.C. Kuenen, Rikke Borg et al. · Diabetes Care · 2008 · 1.8K citations · Full text
Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose
William L. Clarke, Daniel J. Cox, Linda Gonder‐Frederick et al. · Diabetes Care · 1987 · 1.4K citations
Medicine, Endocrinology, Biosensors +16
Helena W. Rodbard, Paul S. Jellinger, Jaime A. Davidson et al. · Endocrine Practice · 2009 · 947 citations